A glimpse of the glomerular milieu: From endothelial cell to thrombotic disease in nephrotic syndrome

Microvascular Research

Volumn 89, Issue , 2013, Pages 1-6

  Chen, Guochun ^a,b   Liu, Hong ^a,b   Liu, Fuyou ^a,b  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBIN III; BLOOD CLOTTING FACTOR 10; BLOOD CLOTTING FACTOR 5; BLOOD CLOTTING FACTOR 8; CD31 ANTIGEN; CYTOKINE; FIBRINOGEN; NITRIC OXIDE; PROTEIN C; PROTEIN S;

BLOOD CLOTTING; ENDOTHELIAL MICROPARTICLE; ENDOTHELIUM CELL; FIBRINOLYSIS; GLOMERULUS; HUMAN; HYPERCOAGULABILITY; KIDNEY VEIN; KIDNEY VEIN THROMBOSIS; MOLECULAR INTERACTION; NEPHROTIC SYNDROME; PATHOGENESIS; PODOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEINURIA; REVIEW; VENOUS THROMBOEMBOLISM;

ANIMALS; ANTIGENS, CD31; BLOOD COAGULATION; CELL-DERIVED MICROPARTICLES; ENDOTHELIAL CELLS; FIBRINOLYSIS; HOMEOSTASIS; HUMANS; KIDNEY; KIDNEY GLOMERULUS; NEPHROTIC SYNDROME; NITRIC OXIDE; PROTEINURIA; RISK; THROMBOEMBOLISM; THROMBOSIS;

EID: 84883179351     PISSN: 00262862     EISSN: 10959319     Source Type: Journal    
DOI: 10.1016/j.mvr.2013.06.011     Document Type: Review

References (83)

1. Abid Hussein M.N., Boing A.N., Biro E., et al. Phospholipid composition of in vitro endothelial microparticles and their in vivo thrombogenic properties. Thromb. Res. 2008, 121:865-871.
2. Akis N., Madaio M.P. Isolation, culture, and characterization of endothelial cells from mouse glomeruli. Kidney Int. 2004, 65:2223-2227.
3. Aras O., Shet A., Bach R.R., et al. Induction of microparticle- and cell-associated intravascular tissue factor in human endotoxemia. Blood 2004, 103:4545-4553.
4. Atochin D.N., Huang P.L. Endothelial nitric oxide synthase transgenic models of endothelial dysfunction. Pflugers Arch. 2010, 460:965-974.
5. Beck L.H., Salant D.J. Membranous nephropathy: recent travels and new roads ahead. Kidney Int. 2010, 77:765-770.
6. Brodsky S.V., Malinowski K., Golightly M., et al. Plasminogen activator inhibitor-1 promotes formation of endothelial microparticles with procoagulant potential. Circulation 2002, 106:2372-2378.
7. Bulger R.E., Eknoyan G., Purcell D.J., et al. Endothelial characteristics of glomerular capillaries in normal, mercuric chloride-induced, and gentamicin-induced acute renal failure in the rat. J. Clin. Invest. 1983, 72:128-141.
8. Burger D., Schock S., Thompson C.S., et al. Microparticles: biomarkers and beyond. Clin. Sci. (Lond.) 2013, 124:423-441.
9. Cai G., Chen X., Fu B., et al. Activation of gelatinases by fibrin is PA/plasmin system-dependent in human glomerular endothelial cells. Mol. Cell. Biochem. 2005, 277:171-179.
10. Carpenter A.W., Schoenfisch M.H. Nitric oxide release: part II. Therapeutic applications. Chem. Soc. Rev. 2012, 41:3742-3752.
11. Chen C.H., Jiang T., Yang J.H., et al. Low-density lipoprotein in hypercholesterolemic human plasma induces vascular endothelial cell apoptosis by inhibiting fibroblast growth factor 2 transcription. Circulation 2003, 107:2102-2108.
12. Chironi G.N., Boulanger C.M., Simon A., et al. Endothelial microparticles in diseases. Cell Tissue Res. 2009, 335:143-151.
13. Chugh K.S., Malik N., Uberoi H.S., et al. Renal vein thrombosis in nephrotic syndrome-a prospective study and review. Postgrad. Med. J. 1981, 57:566-570.
14. Ciarimboli G., Hjalmarsson C., Bokenkamp A., et al. Dynamic alterations of glomerular charge density in fixed rat kidneys suggest involvement of endothelial cell coat. Am. J. Physiol. Renal Physiol. 2003, 285:F722-F730.
15. Collino F., Bussolati B., Gerbaudo E., et al. Preeclamptic sera induce nephrin shedding from podocytes through endothelin-1 release by endothelial glomerular cells. Am. J. Physiol. Renal Physiol. 2008, 294:F1185-F1194.
16. Combes V., Simon A.C., Grau G.E., et al. In vitro generation of endothelial microparticles and possible prothrombotic activity in patients with lupus anticoagulant. J. Clin. Invest. 1999, 104:93-102.
17. Deen W.M. What determines glomerular capillary permeability?. J. Clin. Invest. 2004, 114:1412-1414.
18. Eremina V., Jefferson J.A., Kowalewska J., et al. VEGF inhibition and renal thrombotic microangiopathy. N. Engl. J. Med. 2008, 358:1129-1136.
19. Faure V., Dou L., Sabatier F., et al. Elevation of circulating endothelial microparticles in patients with chronic renal failure. J. Thromb. Haemost. 2006, 4:566-573.
20. Ferrero E., Ferrero M.E., Pardi R., et al. The platelet endothelial cell adhesion molecule-1 (PECAM1) contributes to endothelial barrier function. FEBS Lett. 1995, 374:323-326.
21. Fervenza F.C., Sethi S., Specks U. Idiopathic membranous nephropathy: diagnosis and treatment. Clin. J. Am. Soc. Nephrol. 2008, 3:905-919.
22. Fogo A.B., Kon V. The glomerulus-a view from the inside-the endothelial cell. Int. J. Biochem. Cell Biol. 2010, 42:1388-1397.
23. Frangie C., Lefaucheur C., Medioni J., et al. Renal thrombotic microangiopathy caused by anti-VEGF-antibody treatment for metastatic renal-cell carcinoma. Lancet Oncol. 2007, 8:177-178.
24. Freedman J.E., Loscalzo J. Nitric oxide and its relationship to thrombotic disorders. J. Thromb. Haemost. 2003, 1:1183-1188.
25. Gao C., Xie R., Yu C., et al. Procoagulant activity of erythrocytes and platelets through phosphatidylserine exposure and microparticles release in patients with nephrotic syndrome. Thromb. Haemost. 2012, 107:681-689.
26. George B.A., Zhou X.J., Toto R. Nephrotic syndrome after bevacizumab: case report and literature review. Am. J. Kidney Dis. 2007, 49:e23-e29.
27. Glassock R.J. Prophylactic anticoagulation in nephrotic syndrome: a clinical conundrum. J. Am. Soc. Nephrol. 2007, 18:2221-2225.
28. Glassock R.J. The pathogenesis of idiopathic membranous nephropathy: a 50-year odyssey. Am. J. Kidney Dis. 2010, 56:157-167.
29. Gong N., Chatterjee S. Platelet endothelial cell adhesion molecule in cell signaling and thrombosis. Mol. Cell. Biochem. 2003, 253:151-158.
30. Gouault-Heilmann M., Gadelha-Parente T., Levent M., et al. Total and free protein S in nephrotic syndrome. Thromb. Res. 1988, 49:37-42.
31. Gumina R.J., Kirschbaum N.E., Rao P.N., et al. The human PECAM1 gene maps to 17q23. Genomics 1996, 34:229-232.
32. Haraldsson B., Nystrom J. The glomerular endothelium: new insights on function and structure. Curr. Opin. Nephrol. Hypertens. 2012, 21:258-263.
33. Haraldsson B., Nystrom J., Deen W.M. Properties of the glomerular barrier and mechanisms of proteinuria. Physiol. Rev. 2008, 88:451-487.
34. Hofstra J.M., Wetzels J.F. Management of patients with membranous nephropathy. Nephrol. Dial. Transplant. 2012, 27:6-9.
35. Isome M., Fujinaka H., Yaoita E., et al. Involvement of endothelial cell adhesion molecules in the development of anti-Thy-1 nephritis. Exp. Nephrol. 2002, 10:338-347.
36. Izzedine H., Brocheriou I., Deray G., et al. Thrombotic microangiopathy and anti-VEGF agents. Nephrol. Dial. Transplant. 2007, 22:1481-1482.
37. Jackson D.E. The unfolding tale of PECAM-1. FEBS Lett. 2003, 540:7-14.
38. Jarad G., Miner J.H. Update on the glomerular filtration barrier. Curr. Opin. Nephrol. Hypertens. 2009, 18:226-232.
39. Jeansson M., Haraldsson B. Morphological and functional evidence for an important role of the endothelial cell glycocalyx in the glomerular barrier. Am. J. Physiol. Renal Physiol. 2006, 290:F111-F116.
40. Jimenez J.J., Jy W., Mauro L.M., et al. Endothelial cells release phenotypically and quantitatively distinct microparticles in activation and apoptosis. Thromb. Res. 2003, 109:175-180.
41. Kanfer A. Coagulation factors in nephrotic syndrome. Am. J. Nephrol. 1990, 10(Suppl. 1):63-68.
42. Katavetin P. VEGF inhibition and renal thrombotic microangiopathy. N. Engl. J. Med. 2008, 359:205-206. (author reply 206-207).
43. Kayali F., Najjar R., Aswad F., et al. Venous thromboembolism in patients hospitalized with nephrotic syndrome. Am. J. Med. 2008, 121:226-230.
44. Kerlin B.A., Ayoob R., Smoyer W.E. Epidemiology and pathophysiology of nephrotic syndrome-associated thromboembolic disease. Clin. J. Am. Soc. Nephrol. 2012, 7:513-520.
45. Khan F., Yamakami K., Mahmood J., et al. Alterations of cell adhesion molecules in human glomerular endothelial cells in response to nephritis-associated plasminogen receptor. Nephron Exp. Nephrol. 2007, 105:e53-e64.
46. Leroyer A.S., Anfosso F., Lacroix R., et al. Endothelial-derived microparticles: biological conveyors at the crossroad of inflammation, thrombosis and angiogenesis. Thromb. Haemost. 2010, 104:456-463.
47. Li S.J., Guo J.Z., Zuo K., et al. Thromboembolic complications in membranous nephropathy patients with nephrotic syndrome-a prospective study. Thromb. Res. 2012, 130:501-505.
48. Lijfering W.M., Rosendaal F.R., Cannegieter S.C. Risk factors for venous thrombosis - current understanding from an epidemiological point of view. Br. J. Haematol. 2010, 149:824-833.
49. Llach F. Hypercoagulability, renal vein thrombosis, and other thrombotic complications of nephrotic syndrome. Kidney Int. 1985, 28:429-439.
50. Mahmoodi B.K., ten Kate M.K., Waanders F., et al. High absolute risks and predictors of venous and arterial thromboembolic events in patients with nephrotic syndrome: results from a large retrospective cohort study. Circulation 2008, 117:224-230.
51. Mahooti S., Graesser D., Patil S., et al. PECAM-1 (CD31) expression modulates bleeding time in vivo. Am. J. Pathol. 2000, 157:75-81.
52. Makker S.P., Tramontano A. Idiopathic membranous nephropathy: an autoimmune disease. Semin. Nephrol. 2011, 31:333-340.
53. McGinley E., Lowe G.D., Boulton-Jones M., et al. Blood viscosity and haemostasis in the nephrotic syndrome. Thromb. Haemost. 1983, 49:155-157.
54. Mineo C. Inhibition of nitric oxide and antiphospholipid antibody-mediated thrombosis. Curr. Rheumatol. Rep. 2013, 15:324.
55. Nagao T., Matsumura M., Mabuchi A., et al. Up-regulation of adhesion molecule expression in glomerular endothelial cells by anti-myeloperoxidase antibody. Nephrol. Dial. Transplant. 2007, 22:77-87.
56. Nakayama T., Sato W., Yoshimura A., et al. Endothelial von Willebrand factor release due to eNOS deficiency predisposes to thrombotic microangiopathy in mouse aging kidney. Am. J. Pathol. 2010, 176:2198-2208.
57. Navar L.G. Glomerular permeability: a never-ending saga. Am. J. Physiol. Renal Physiol. 2009, 296:F1266-F1268.
58. Neal C.R., Crook H., Bell E., et al. Three-dimensional reconstruction of glomeruli by electron microscopy reveals a distinct restrictive urinary subpodocyte space. J. Am. Soc. Nephrol. 2005, 16:1223-1235.
59. Nystrom J., Fierlbeck W., Granqvist A., et al. A human glomerular SAGE transcriptome database. BMC Nephrol. 2009, 10:13.
60. Obeidat M., Ballermann B.J. Glomerular endothelium: a porous sieve and formidable barrier. Exp. Cell Res. 2012, 318:964-972.
61. Owens A.P., Mackman N. Microparticles in hemostasis and thrombosis. Circ. Res. 2011, 108:1284-1297.
62. Pala L., Cresci B., Manuelli C., et al. Vascular endothelial growth factor receptor-2 and low affinity VEGF binding sites on human glomerular endothelial cells: biological effects and advanced glycosilation end products modulation. Microvasc. Res. 2005, 70:179-188.
63. Panzer U., Steinmetz O.M., Reinking R.R., et al. Compartment-specific expression and function of the chemokine IP-10/CXCL10 in a model of renal endothelial microvascular injury. J. Am. Soc. Nephrol. 2006, 17:454-464.
64. Ponticelli C. Membranous nephropathy. J. Nephrol. 2007, 20:268-287.
65. Rivera J., Lozano M.L., Navarro-Nunez L., et al. Platelet receptors and signaling in the dynamics of thrombus formation. Haematologica 2009, 94:700-711.
66. Sabatier F., Roux V., Anfosso F., et al. Interaction of endothelial microparticles with monocytic cells in vitro induces tissue factor-dependent procoagulant activity. Blood 2002, 99:3962-3970.
67. Salmon A.H., Toma I., Sipos A., et al. Evidence for restriction of fluid and solute movement across the glomerular capillary wall by the subpodocyte space. Am. J. Physiol. Renal Physiol. 2007, 293:F1777-F1786.
68. Salmon A.H., Neal C.R., Harper S.J. New aspects of glomerular filtration barrier structure and function: five layers (at least) not three. Curr. Opin. Nephrol. Hypertens. 2009, 18:197-205.
69. Sapet C., Simoncini S., Loriod B., et al. Thrombin-induced endothelial microparticle generation: identification of a novel pathway involving ROCK-II activation by caspase-2. Blood 2006, 108:1868-1876.
70. Schnaper H.W. Antithrombin III, protein S, and coagulation in the nephrotic syndrome. Pediatr. Nephrol. 2001, 16:98.
71. Shao J., Miyata T., Yamada K., et al. Protective role of nitric oxide in a model of thrombotic microangiopathy in rats. J. Am. Soc. Nephrol. 2001, 12:2088-2097.
72. Shet A.S., Aras O., Gupta K., et al. Sickle blood contains tissue factor-positive microparticles derived from endothelial cells and monocytes. Blood 2003, 102:2678-2683.
73. Shultz P.J., Raij L. Endogenously synthesized nitric oxide prevents endotoxin-induced glomerular thrombosis. J. Clin. Invest. 1992, 90:1718-1725.
74. Singhal R., Brimble K.S. Thromboembolic complications in the nephrotic syndrome: pathophysiology and clinical management. Thromb. Res. 2006, 118:397-407.
75. Sprangers B., Bomback A.S., Cohen S.D., et al. Idiopathic membranous nephropathy: clinical and histologic prognostic features and treatment patterns over time at a tertiary referral center. Am. J. Nephrol. 2012, 36:78-89.
76. Stokes M.B., Erazo M.C., D'Agati V.D. Glomerular disease related to anti-VEGF therapy. Kidney Int. 2008, 74:1487-1491.
77. Szotowski B., Antoniak S., Goldin-Lang P., et al. Antioxidative treatment inhibits the release of thrombogenic tissue factor from irradiation- and cytokine-induced endothelial cells. Cardiovasc. Res. 2007, 73:806-812.
78. Thongboonkerd V. Proteomics in nephrology: current status and future directions. Am. J. Nephrol. 2004, 24:360-378.
79. Tsai H.M. The molecular biology of thrombotic microangiopathy. Kidney Int. 2006, 70:16-23.
80. Vigano-D'Angelo S., D'Angelo A., Kaufman C.E., et al. Protein S deficiency occurs in the nephrotic syndrome. Ann. Intern. Med. 1987, 107:42-47.
81. Wang J.M., Wang Y., Huang J.Y., et al. C-Reactive protein-induced endothelial microparticle generation in HUVECs is related to BH4-dependent NO formation. J. Vasc. Res. 2007, 44:241-248.
82. Woodfin A., Voisin M.B., Nourshargh S. PECAM-1: a multi-functional molecule in inflammation and vascular biology. Arterioscler. Thromb. Vasc. Biol. 2007, 27:2514-2523.
83. Zhang J.J., Kelm R.J., Biswas P., et al. PECAM-1 modulates thrombin-induced tissue factor expression on endothelial cells. J. Cell. Physiol. 2007, 210:527-537.